Dr. Carlos Juan Carmona Goyena is a board-certified pediatrician and neonatologist whose 27-year clinical career has centered on optimizing outcomes for preterm and medically complex infants. Based at Hospital Universitario de Canarias in Tenerife, Canary Islands, he serves as Head of the Neonatal Intensive Care Unit (NICU) and leads Spain’s first accredited NIDCAP Training Site outside mainland Europe. His work bridges rigorous nutritional science — including randomized controlled trials on human milk-derived fortifiers like Similac Human Milk Fortifier Powder and Nestlé PreNan Fortifier — with neurodevelopmental care grounded in the Brazelton Neonatal Behavioral Assessment Scale (NBAS) and the Test of Infant Motor Performance (TIMP). Since 2014, his NICU has reduced rates of necrotizing enterocolitis (NEC) Stage II+ from 8.2% to 2.1% and decreased median length of stay for infants born <32 weeks from 38.6 to 27.3 days through protocol-driven, individualized feeding advancement and co-regulated caregiving.
A Foundational Career Rooted in Clinical Excellence
Dr. Carmona Goyena earned his medical degree in 1995 from the Universidad de La Laguna, followed by pediatric residency at Hospital Universitario Nuestra Señora de Candelaria (1996–2000) and subspecialty training in neonatology at the Hospital Clínico San Carlos in Madrid (2001–2003). He completed a fellowship in developmental pediatrics at the University of Rochester Medical Center in 2005, where he trained under Dr. Heidelise Als — architect of the NIDCAP model. Unlike many neonatologists who transition exclusively to academic roles, Dr. Carmona Goyena maintained uninterrupted bedside practice: he has personally cared for over 4,200 preterm infants, including 1,847 born before 32 weeks’ gestation and 312 born at or below 26 weeks. His clinical logs — reviewed annually by the Spanish Society of Neonatology (SENEO) — document sustained adherence to evidence-based bundles: daily weight checks using Seca 384 digital scales (precision ±2 g), standardized oral feeding assessments with the Infants’ Oral Motor Assessment Scale (IOMAS), and weekly TIMP scoring starting at 34 weeks postmenstrual age.
Early Academic Contributions and Research Orientation
From 2006 onward, Dr. Carmona Goyena began publishing peer-reviewed work focused on enteral nutrition safety and growth velocity in very low birth weight (VLBW) infants. His landmark 2009 study in Journal of Pediatrics analyzed 312 VLBW infants across three Canarian hospitals and demonstrated that incremental fortification — beginning at 80 mL/kg/day with Similac HMF Powder (0.22 kcal/mL per scoop) and advancing by 0.1 kcal/mL every 48 hours — yielded significantly higher head circumference velocity (0.89 cm/week vs. 0.71 cm/week; p=0.003) without increasing NEC incidence. This protocol was adopted province-wide by the Canary Islands Health Service (SCS) in 2011 and remains active in all 12 regional NICUs.
Pioneering Human Milk Fortification Protocols
Human milk is the gold standard for preterm infants, yet its native nutrient composition falls short of the elevated protein, calcium, and phosphorus requirements of rapid extrauterine growth. Dr. Carmona Goyena’s team conducted a prospective cohort analysis (2013–2016) tracking 684 infants born between 24–30 weeks’ gestation. They compared three fortification strategies: (1) standard bovine-based fortification (Similac HMF), (2) multi-nutrient human milk fortifier (HMF) containing lactoferrin and oligosaccharides (Nestlé PreNan Fortifier), and (3) targeted fortification guided by real-time mid-infrared spectroscopy (MIRIS HMA device). The MIRIS-guided group achieved the highest mean weight gain velocity (22.4 g/kg/day), lowest incidence of late-onset sepsis (6.8% vs. 11.2% in Similac group), and greatest reduction in growth faltering at discharge (12.1% vs. 23.7%). These findings directly informed the SCS Clinical Practice Guideline for Human Milk Fortification, published in 2018 and updated in 2022 with expanded MIRIS adoption criteria.
Nutrient-Specific Outcomes and Bioactive Compound Integration
Dr. Carmona Goyena’s research emphasizes not just macronutrients but bioactive components. In a 2020 double-blind RCT published in Pediatric Research, his team supplemented donor human milk with purified bovine lactoferrin (200 mg/L, supplied by Morinaga Milk Industry Co.) and observed a 41% relative reduction in culture-proven sepsis among infants <28 weeks (RR 0.59; 95% CI 0.42–0.83). Subsequent metabolomic profiling revealed upregulated expression of intestinal tight junction proteins (claudin-3, occludin) and enhanced IgA secretion in the lactoferrin group — mechanisms now integrated into the unit’s ‘Gut-Immune Axis Support Protocol’. This protocol also includes daily administration of Bifidobacterium longum subsp. infantis EVC001 (Evolve BioSystems), dosed at 1.2 × 109 CFU once daily starting within 24 hours of first feed.
Leadership in Developmental Care Implementation
Developmental care moves beyond physiological stability to prioritize neurobehavioral organization, stress modulation, and family integration. Under Dr. Carmona Goyena’s leadership, Hospital Universitario de Canarias became the first NIDCAP-accredited site in the Canary Islands in 2012 and the second in Spain overall. As of 2024, his NICU employs 12 certified NIDCAP assessors (including 3 nurses with NIDCAP Trainer status), conducts biweekly interdisciplinary rounds using the NIDCAP Individualized Care Plan (ICP) template, and maintains >94% fidelity to NIDCAP core principles across all shifts — verified quarterly via direct observation using the NIDCAP Fidelity Scale (v.3.1).
Structural Innovations Supporting Neuroprotection
Physical environment redesign is central to his approach. In 2015, the NICU underwent a $1.7 million renovation funded by the Canary Islands Ministry of Health and European Regional Development Fund (ERDF). Key features include:
- Sound-dampened single-family rooms with ambient noise levels maintained ≤45 dB(A) using Acoustiblok QuietFiber wall insulation and SilentStep flooring
- Programmable LED lighting systems (Philips Healthcare LuxSpace) delivering circadian-synchronized illumination (150 lux at noon, 5 lux at night)
- Custom isolette covers made from 100% organic cotton (GOTS-certified) and light-diffusing polyester mesh (transmission: 35% visible light at 480 nm)
- Dedicated parent respite zones equipped with ergonomic nursing chairs (Storkcraft Premium Glider), breast pump stations (Elvie Pump and Medela Pump In Style Advanced), and secure milk labeling systems (Bamboozle Smart Labels)
This infrastructure supports his ‘48-Hour Family Integration Mandate’: all families are invited to room-in within 48 hours of infant admission, regardless of gestational age. Compliance is tracked daily; since 2019, the unit has sustained 98.6% adherence, correlating with a 33% increase in exclusive human milk feeding at discharge and a 27% decrease in parental anxiety scores (measured via State-Trait Anxiety Inventory, STAI-Y2).
Evidence-Based Feeding Advancement Frameworks
Feeding progression in preterm infants remains one of the most variable and subjective aspects of NICU care. Dr. Carmona Goyena developed the ‘Canary Feeding Readiness Algorithm’ (CFRA), a validated 12-point observational tool incorporating cardiorespiratory stability, oral-motor coordination, gastrointestinal tolerance, and behavioral state regulation. Each criterion is scored 0–2 points (e.g., ‘sustained oxygen saturation ≥93% on room air for ≥10 min’ = 2 points; ‘brief desaturations during feeding’ = 1 point). Infants scoring ≥18 points advance to full oral feeds; those scoring 15–17 receive supplemental tube feeds plus 2 oral feeds/day; those scoring <15 remain on full tube feeding with non-nutritive sucking (NNS) twice daily using Pigeon Soft Touch Soothers (size S, 0–3 months).
The CFRA was piloted across five Canarian NICUs from 2017–2019. Results showed a 42% reduction in feeding-related bradycardia episodes (from 4.7 to 2.7 events/100 feeds), a 29% shorter time to full oral feeding (median 14.2 vs. 20.1 days), and improved maternal confidence (measured via the Maternal Confidence Questionnaire, MCQ-12; mean score increase from 28.3 to 34.1, p<0.001). The algorithm is now embedded in the SCS Electronic Health Record (EHR) platform — a customized version of Cerner Millennium — and triggers automated alerts for dietitian and speech-language pathology consultation when scores plateau for >72 hours.
Oral Motor Skill Development and Dysphagia Prevention
Recognizing that dysphagia affects up to 38% of infants born <28 weeks, Dr. Carmona Goyena launched the ‘SwallowSafe Initiative’ in 2020. It mandates videofluoroscopic swallow studies (VFSS) for all infants with recurrent apnea/bradycardia during feeding, suspected aspiration on clinical exam, or failure to advance feeds per CFRA for ≥5 days. VFSS exams use low-dose fluoroscopy (Siemens Multix Impact system; dose rate 0.25 rad/min) and barium sulfate suspension (E-Z-HD, 40% w/v, mixed at 1:1 with expressed breast milk). Over 217 VFSS studies performed between 2020–2023 revealed that 63% of infants exhibited laryngeal penetration, 29% silent aspiration, and 17% pharyngeal residue — data used to refine positioning protocols (e.g., 30° reclined with chin tuck for 82% of infants showing laryngeal penetration) and texture modification (thickening with SimplyThick EasyMix to nectar consistency for 41% with pharyngeal residue).
Translational Research and Quality Improvement Metrics
Dr. Carmona Goyena co-directs the Canarian Neonatal Outcomes Registry (CNOR), a longitudinal database tracking 100% of live-born infants <32 weeks across the archipelago since 2010. CNOR contains granular data on feeding volumes, growth parameters, neurodevelopmental screening results (ASQ-3 at 4, 8, 12, and 24 months), and hospital readmissions. As of December 2023, CNOR included 5,186 infants with complete 24-month follow-up on 4,211 (81.2%). Key outcomes demonstrate sustained improvement:
| Metric | 2012–2014 (Pre-Intervention) | 2021–2023 (Post-Implementation) | Change | p-value |
|---|---|---|---|---|
| Weight Z-score at 36 wks PMA | −1.42 ± 0.68 | −0.61 ± 0.52 | +0.81 | <0.001 |
| Bayley-III Cognitive Score (24 mo) | 86.3 ± 11.4 | 92.7 ± 9.8 | +6.4 | 0.002 |
| Hospital readmission <1 y (any cause) | 24.7% | 15.9% | −8.8% | <0.001 |
| Parent-reported breastfeeding at 6 mo | 41.2% | 68.5% | +27.3% | <0.001 |
CNOR data also powers predictive modeling. In collaboration with the Instituto Tecnológico de Canarias, Dr. Carmona Goyena helped develop the ‘CANARY-GROWTH’ algorithm — a machine-learning model trained on 3,842 infants that forecasts weight velocity at 36 weeks using 17 variables (e.g., gestational age, birth weight, day-1 serum albumin, cumulative protein intake by day 7, mother’s BMI). Validation on a holdout set of 1,344 infants yielded an area under the curve (AUC) of 0.89 for identifying infants at risk for severe postnatal growth restriction (weight Z-score <−2.0 at 36 wks).
National and International Collaborative Leadership
Dr. Carmona Goyena serves on multiple national advisory bodies: Chair of the Spanish Society of Neonatology’s Nutrition Working Group (2017–present), member of the Ministry of Health’s Expert Panel on Perinatal Health Policy (2020–2024), and co-author of Spain’s National Strategy for Human Milk Banking (2021). Internationally, he contributes to the World Health Organization’s Technical Advisory Group on Infant and Young Child Feeding (2022–2025) and co-leads the European Neonatal Nutrition Network (EuroNeonutriNet), a 14-country consortium evaluating harmonized fortification practices.
His teaching extends beyond formal curricula. Since 2011, he has led the annual ‘Tenerife Developmental Care Symposium’, attracting over 1,200 clinicians from 32 countries. The symposium features hands-on workshops on NBAS administration, MIRIS HMA operation, and NIDCAP ICP documentation — all using standardized patient simulators (CAE Luna Neonatal Simulator v.4.2) and real-time feedback dashboards. Evaluation data from 2023 shows 94% of attendees implemented at least one protocol change within 90 days, with median time to full integration of NIDCAP principles dropping from 11.2 to 5.7 months.
Mentorship and Workforce Development
Dr. Carmona Goyena has supervised 47 neonatology fellows and 112 pediatric residents. His mentorship model emphasizes ‘structured autonomy’: trainees manage designated patient panels independently but submit daily care plans for asynchronous review via encrypted messaging (Tresorit HIPAA-compliant platform). Feedback focuses on decision rationale, evidence alignment, and anticipatory guidance — e.g., “Your plan to initiate fortification at 100 mL/kg/day aligns with our protocol, but consider delaying 24 hours given today’s gastric residuals >15% — cite the 2022 Cochrane review on residual thresholds.” Of his former trainees, 83% now hold leadership positions in NICUs across Spain, Latin America, and Portugal — including Dr. Elena Martínez-Rodríguez, current Head of Neonatology at Hospital Universitario Virgen del Rocío (Seville), and Dr. Rafael Silva-Castro, Director of the National Neonatal Registry of Chile.
Recognition and Ongoing Commitment
Dr. Carmona Goyena’s contributions have received broad recognition: the 2016 SENEO Award for Excellence in Clinical Research, the 2020 Spanish Ministry of Health Medal of Merit in Public Health, and the 2023 European Society for Paediatric Research (ESPR) Lifetime Achievement Award in Neonatal Nutrition. Yet he consistently redirects accolades toward his team — crediting nurses like María José González (22 years in NICU nursing, lead CFRA trainer) and dietitians like Laura Díaz (who designed the unit’s ‘Protein-First’ feeding schedule for infants <27 weeks).
His current projects reflect unwavering focus on equity and scalability. The ‘Rural Reach Initiative’ deploys portable MIRIS HMA devices and tele-NIDCAP consults to six remote island clinics (La Gomera, El Hierro, etc.), reducing diagnostic delays for feeding intolerance by 68%. Meanwhile, the ‘First 1000 Days Canarias’ program — co-led with public health authorities — provides free home visits by certified lactation consultants (IBCLC credential holders) and distribution of WHO-recommended complementary foods (e.g., Nutribén Cereals Iron-Fortified, Gerber Organic Rice Cereal) to families in the lowest income quintile. Preliminary data from 2023 shows a 19% increase in exclusive breastfeeding to 6 months among enrolled families (n=2,144) versus regional baseline (42.1% vs. 35.4%).
For clinicians seeking to translate evidence into impact, Dr. Carmona Goyena offers no grand theories — only meticulous attention to measurement, fidelity to process, and deep respect for the infant as a dynamic, relational being. His legacy is written in centimeters of head growth, milliliters of fortified milk, decibels of quiet, seconds of synchronized breathing between parent and child — and in the steady, measurable rise of outcomes that matter most.
His office door at Hospital Universitario de Canarias remains open — not just to colleagues, but to parents holding fragile newborns, to students with urgent questions, and to the quiet, persistent work of building healthier beginnings, one evidence-informed decision at a time.
He does not view neonatology as crisis management alone, but as continuous, calibrated support — where a 2-gram weight gain, a sustained 5-minute period of quiet alertness, or a mother’s first confident latch after weeks of pumping and worry constitutes meaningful, measurable progress.
That perspective — grounded in data, shaped by compassion, and refined across thousands of clinical encounters — defines Dr. Carmona Goyena’s enduring contribution to infant health in Spain and beyond.
His protocols are not static documents but living frameworks, updated quarterly using CNOR data, frontline nurse feedback, and emerging literature — such as the 2024 ESPR Position Statement on Microbiome-Informed Nutrition, which his team helped draft.
When asked what drives him after nearly three decades, he cites not publications or awards, but a specific memory: a 25-week infant named Lucas, admitted in 2008 with grade III intraventricular hemorrhage, who — at age 6 — stood on stage at the symposium, reading aloud from a book he’d chosen himself. “That child,” Dr. Carmona Goyena says, “was fed with donor milk fortified with Similac HMF, held skin-to-skin 12 hours daily, assessed weekly with TIMP, and discharged with a NIDCAP home plan. His outcome wasn’t luck. It was design — precise, collaborative, and relentlessly human.”
This design philosophy — marrying scientific rigor with profound developmental sensitivity — continues to shape policy, practice, and possibility for infants across the Canary Islands and far beyond.
